Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Short Interest Update

Curaleaf Holdings, Inc. (OTCMKTS:CURLFGet Free Report) was the target of a significant decline in short interest in January. As of January 31st, there was short interest totalling 6,337,300 shares, a decline of 9.0% from the January 15th total of 6,962,300 shares. Based on an average daily volume of 1,348,400 shares, the days-to-cover ratio is presently 4.7 days.

Wall Street Analyst Weigh In

CURLF has been the subject of several research analyst reports. Cormark cut Curaleaf from a “moderate buy” rating to a “hold” rating in a research note on Thursday, November 7th. Roth Capital upgraded Curaleaf to a “strong-buy” rating in a research report on Sunday, November 10th.

Read Our Latest Analysis on Curaleaf

Curaleaf Trading Down 1.3 %

Curaleaf stock traded down $0.02 during trading hours on Monday, reaching $1.48. 406,433 shares of the company’s stock were exchanged, compared to its average volume of 791,787. The firm’s 50 day simple moving average is $1.50 and its 200 day simple moving average is $2.35. Curaleaf has a twelve month low of $0.88 and a twelve month high of $6.40. The company has a quick ratio of 0.51, a current ratio of 1.11 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $971.01 million, a PE ratio of -5.10 and a beta of 0.60.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.